These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7195856)

  • 21. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.
    Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of heterozygosity of women with respect to the phenylketonuria gene in the origin of spontaneous abortions and disturbances of intrauterine fetal development.
    Blyumina MG
    Sov Genet; 1974 May; 8(3):385-90. PubMed ID: 4846205
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine.
    Jagenburg R; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1661-5. PubMed ID: 890910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenylketonuria and hyperphenylalaninemia: clinico-genetic classification of 14 forms].
    Annenkov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):351-6. PubMed ID: 6720175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
    Thöny B; Ding Z; Martínez A
    FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal phenylketonuria.
    Paprocka J; Jamroz E; Wiktor M; Marszał E
    Wiad Lek; 2009; 62(1):11-7. PubMed ID: 19817251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered brain gene expression profiles associated with the pathogenesis of phenylketonuria in a mouse model.
    Park JW; Park ES; Choi EN; Park HY; Jung SC
    Clin Chim Acta; 2009 Mar; 401(1-2):90-9. PubMed ID: 19073163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of heterozygote carrier state of phenylketonuria gene].
    D'iachkova AIa; Lebedev BV
    Pediatriia; 1969 Aug; 48(8):50-3. PubMed ID: 5354560
    [No Abstract]   [Full Text] [Related]  

  • 30. [Maternal phenylketonuria syndrome: teratogenic effect of hyperphenylalaninemia].
    Szabó L; Somogyi C; Máté M
    Orv Hetil; 1982 Nov; 123(47):2895-901. PubMed ID: 7177638
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of heterozygotes for phenylketonuria by column chromatography and discriminatory analysis.
    Rampini S; Anders PW; Curtius HC; Marthaler T
    Pediatr Res; 1969 Jul; 3(4):287-97. PubMed ID: 5807058
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical phenotype and its relationship with genotype in hyperphenylalaninemia heterozygotes.
    Mallolas J; Milà M; Lambruschini N; Cambra FJ; Campistol J; Vilaseca MA
    Mol Genet Metab; 1999 Jun; 67(2):156-61. PubMed ID: 10356315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.
    Buist NR; Tuerck J; Lis E; Penn R
    N Engl J Med; 1984 Jul; 311(1):52-3. PubMed ID: 6727966
    [No Abstract]   [Full Text] [Related]  

  • 36. Intracellular concentrations of phenylalanine, tyrosine and alpha-aminobutyric acid in 13 homozygotes and 19 heterozygotes for phenylketonuria compared with 26 normals.
    Thalhammer O; Pollak A; Lubec G; Königshofer H
    J Inherit Metab Dis; 1981; 4(2):73-4. PubMed ID: 6790854
    [No Abstract]   [Full Text] [Related]  

  • 37. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.
    Waters PJ
    Hum Mutat; 2003 Apr; 21(4):357-69. PubMed ID: 12655545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in protein aggregation and degradation due to mild and severe missense mutations (A104D, R157N) in the human phenylalanine hydroxylase gene (PAH).
    Waters PJ; Parniak MA; Hewson AS; Scriver CR
    Hum Mutat; 1998; 12(5):344-54. PubMed ID: 9792411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumption of aspartame by heterozygotes for phenylketonuria.
    Freedman M
    J Pediatr; 1987 Apr; 110(4):662-3. PubMed ID: 3559821
    [No Abstract]   [Full Text] [Related]  

  • 40. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype.
    Lindner M; Haas D; Mayatepek E; Zschocke J; Burgard P
    Mol Genet Metab; 2001 May; 73(1):104-6. PubMed ID: 11350190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.